Agios Pharmaceuticals, Inc. (0HB0.L)

USD 41.74

(-0.05%)

Eps Summary of Agios Pharmaceuticals, Inc.

  • Agios Pharmaceuticals, Inc.'s latest annual eps in 2023 was -6.33 USD , down -49.65% from previous year.
  • Agios Pharmaceuticals, Inc.'s latest quarterly eps in 2024 Q3 was 16.65 USD , up 1085.21% from previous quarter.
  • Agios Pharmaceuticals, Inc. reported an annual eps of -4.23 USD in 2022, up 33.49% from previous year.
  • Agios Pharmaceuticals, Inc. reported an annual eps of -6.36 USD in 2021, down -34.18% from previous year.
  • Agios Pharmaceuticals, Inc. reported a quarterly eps of 16.65 USD for 2024 Q3, up 1085.21% from previous quarter.
  • Agios Pharmaceuticals, Inc. reported a quarterly eps of -1.45 USD for 2024 Q1, up 15.7% from previous quarter.

Annual Eps Chart of Agios Pharmaceuticals, Inc. (2023 - 2012)

Historical Annual Eps of Agios Pharmaceuticals, Inc. (2023 - 2012)

Year Eps Eps Growth
2023 -6.33 USD -49.65%
2022 -4.23 USD 33.49%
2021 -6.36 USD -34.18%
2020 -4.74 USD 30.9%
2019 -6.86 USD -13.76%
2018 -6.03 USD 10.67%
2017 -6.75 USD -33.14%
2016 -5.07 USD -60.95%
2015 -3.15 USD -98.11%
2014 -1.59 USD 43.82%
2013 -2.83 USD 64.71%
2012 -8.02 USD 0.0%

Peer Eps Comparison of Agios Pharmaceuticals, Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD -213.366%
Dynavax Technologies Corporation -0.05 USD -12662.097%
Supernus Pharmaceuticals, Inc. 0.02 USD 26365.56%
Perrigo Company plc -0.09 USD -6641.214%
Illumina, Inc. -7.35 USD 13.878%
Thermo Fisher Scientific Inc. 15.53 USD 140.76%
Iovance Biotherapeutics, Inc. -1.89 USD -234.921%
Walgreens Boots Alliance, Inc. -10.01 USD 36.763%
IQVIA Holdings Inc. 7.39 USD 185.656%
Heron Therapeutics, Inc. -0.80 USD -691.25%
Regeneron Pharmaceuticals, Inc. 37.05 USD 117.085%
Unity Biotechnology, Inc. -2.70 USD -134.444%
Waters Corporation 10.87 USD 158.234%
Biogen Inc. 8.02 USD 178.928%
Sangamo Therapeutics, Inc. -1.48 USD -327.703%
Evolus, Inc. -1.08 USD -486.111%
Adicet Bio, Inc. -3.31 USD -91.239%
Cara Therapeutics, Inc. -2.19 USD -189.041%
bluebird bio, Inc. -1.93 USD -227.979%
Esperion Therapeutics, Inc. -2.03 USD -211.823%
FibroGen, Inc. -2.92 USD -116.781%
Agilent Technologies, Inc. 4.22 USD 250.0%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 38.603%
Homology Medicines, Inc. -7.41 USD 14.575%
Geron Corporation -0.32 USD -1878.125%
Alnylam Pharmaceuticals, Inc. -3.52 USD -79.83%
Amicus Therapeutics, Inc. -0.51 USD -1141.176%
Myriad Genetics, Inc. -1.39 USD -355.396%
Viking Therapeutics, Inc. -0.91 USD -595.604%
Intellia Therapeutics, Inc. -5.42 USD -16.79%
Zoetis Inc. 5.08 USD 224.606%
Abeona Therapeutics Inc. -2.53 USD -150.198%
Mettler-Toledo International Inc. 36.10 USD 117.535%
BioMarin Pharmaceutical Inc. 0.89 USD 811.236%
Vertex Pharmaceuticals Incorporated 14.05 USD 145.053%
Kala Pharmaceuticals, Inc. -17.35 USD 63.516%
Ionis Pharmaceuticals, Inc. -2.56 USD -147.266%
Atara Biotherapeutics, Inc. -65.18 USD 90.288%
Verastem, Inc. -3.96 USD -59.848%
Nektar Therapeutics -1.45 USD -336.552%
Axsome Therapeutics, Inc. -5.27 USD -20.114%
Aclaris Therapeutics, Inc. -1.27 USD -398.425%
Sarepta Therapeutics, Inc. -5.80 USD -9.138%
OPKO Health, Inc. -0.25 USD -2432.0%
Exelixis, Inc. 0.65 USD 1073.846%
Neurocrine Biosciences, Inc. 2.56 USD 347.266%
Corcept Therapeutics Incorporated 1.02 USD 720.588%
Anavex Life Sciences Corp. -0.60 USD -955.0%
uniQure N.V. -6.47 USD 2.164%
Imunon, Inc. -2.16 USD -193.056%
Blueprint Medicines Corporation -8.37 USD 24.373%
Insmed Incorporated -5.34 USD -18.539%
Halozyme Therapeutics, Inc. 2.13 USD 397.183%
TG Therapeutics, Inc. 0.09 USD 7188.466%
Incyte Corporation 2.67 USD 337.079%
Emergent BioSolutions Inc. -14.85 USD 57.374%